文献速递脑血管病

脑小血管病与脑出血后功能结局预测

Cerebral Small Vessel Disease and Functional Outcome Prediction After Intracerebral Hemorrhage.
PubMed 文献 · Neurology · 2021-02-24

该多中心前瞻性队列纳入864例急性脑出血患者,评估CT脑小血管病标志物与6个月功能结局的关联。结果显示白质低密度、皮层萎缩、深部萎缩及严重萎缩独立关联不良结局,但加入这些标志物未显著改善ICH评分判别力。

要点

  • CT脑小血管病标志物与脑出血后6个月不良功能结局独立相关。
  • 白质低密度、皮层萎缩、深部萎缩及严重萎缩均增加不良结局风险。
  • 在ICH评分基础上加入SVD标志物未显著提升判别力。

核心结论

  • ICH评分对脑出血后6个月功能结局具有可接受的判别力,CT脑小血管病标志物与结局相关但未显著改善评分判别力。

研究设计与样本

  • 多中心、医院为基础的前瞻性队列研究,纳入864例急性脑出血患者。

主要发现

  • 在多变量模型中校正ICH评分组分后,白质低密度存在(OR 1.52,95%CI 1.12-2.06)、皮层萎缩存在(OR 1.80,95%CI 1.19-2.73)、深部萎缩存在(OR 1.66,95%CI 1.17-2.34)及严重萎缩(深部或皮层)(OR 1.94,95%CI 1.36-2.74)均独立关联不良功能结局。
  • 修订版ICH评分的AUROC为0.71(95%CI 0.68-0.74),加入SVD标志物未显著改善判别力,最佳模型(加入严重萎缩)AUROC为0.73(95%CI 0.69-0.76)。
  • 分别考虑脑叶和非脑叶出血时,上述结果得到验证。

关键数值与推荐

  • 不良功能结局定义为6个月改良Rankin量表评分>2。
  • 采用AUROC和Hosmer-Lemeshow检验评估ICH评分的判别力和校准度。

临床怎么用

  • CT脑小血管病标志物可用于识别脑出血后不良功能结局高风险患者,但不足以替代或显著提升ICH评分。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To determine whether CT-based cerebral small vessel disease (SVD) biomarkers are associated with 6-month functional outcome after intracerebral hemorrhage (ICH) and whether these biomarkers improve the performance of the preexisting ICH prediction score. METHODS: We included 864 patients with acute ICH from a multicenter, hospital-based prospective cohort study. We evaluated CT-based SVD biomarkers (white matter hypodensities [WMH], lacunes, brain atrophy, and a composite SVD burden score) and their associations with poor 6-month functional outcome (modified Rankin Scale score >2). The area under the receiver operating characteristic curve (AUROC) and Hosmer-Lemeshow test were used to assess discrimination and calibration of the ICH score with and without SVD biomarkers. RESULTS: In multivariable models (adjusted for ICH score components), WMH presence (odds ratio [OR] 1.52, 95% confidence interval [CI] 1.12-2.06), cortical atrophy presence (OR 1.80, 95% CI 1.19-2.73), deep atrophy presence (OR 1.66, 95% CI 1.17-2.34), and severe atrophy (either deep or cortical) (OR 1.94, 95% CI 1.36-2.74) were independently associated with poor functional outcome. For the revised ICH score, the AUROC was 0.71 (95% CI 0.68-0.74). Adding SVD markers did not significantly improve ICH score discrimination; for the best model (adding severe atrophy), the AUROC was 0.73 (95% CI 0.69-0.76). These results were confirmed when lobar and nonlobar ICH were considered separately. CONCLUSIONS: The ICH score has acceptable discrimination for predicting 6-month functional outcome after ICH. CT biomarkers of SVD are associated with functional outcome, but adding them does not significantly improve ICH score discrimination. TRIAL REGISTRATION INFORMATION: ClinicalTrials.gov Identifier: NCT02513316.

来源:Neurology,查看原文。版权归原作者所有。

引用

  1. Hostettler IC, Schwarz G, Ambler G, et al. Cerebral Small Vessel Disease and Functional Outcome Prediction After Intracerebral Hemorrhage. Neurology. 2021. PMID: 33627495. doi:10.1212/WNL.0000000000011746

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。